Inscrivez-vous 01 49 36 46 20
Date de publication : 20/11/2020
Date de péremption :
Type de procédure : Négociée sans mise en concurrence
Type de document : Avis d'attribution

Royaume-Uni-Londres: VÍtements de protection biologique et chimique

2020/S 227-560518  (Source TED)
V  E  R  S  I  O  N      F  R  A  N  C  A  I  S  E
TX: 20/11/2020 S227 Royaume-Uni-Londres: VÍtements de protection biologique et chimique 2020/S 227-560518 Avis díattribution de marchÈ RÈsultats de la procÈdure de marchÈ Fournitures
Section I: Pouvoir adjudicateur
I.1) Nom et adresses Nom officiel: Department of Health and Social Care Adresse postale: 39 Victoria Street Ville: London Code NUTS: UKI32 Westminster Code postal: SW1H 0EU Pays: Royaume-Uni Courriel: Adresse(s) internet:
Adresse principale: Adresse du profil díacheteur:
I.4) Type de pouvoir adjudicateur MinistËre ou toute autre autoritÈ nationale ou fÈdÈrale, y compris leurs subdivisions rÈgionales ou locales
I.5) ActivitÈ principale SantÈ
Section II: Objet
II.1) ...tendue du marchÈ
II.1.1) IntitulÈ:
Supply of Personal Protective Equipment for Healthcare Workers for the Care of Patients with Suspected or Confirmed Novel Coronavirus (Covid-19)
II.1.2) Code CPV principal 35113410 VÍtements de protection biologique et chimique
II.1.3) Type de marchÈ Fournitures
II.1.4) Description succincte:
The Department of Health and Social Care (the ëAuthorityí) has awarded a contract to Uniserve Group for the supply of Personal Protective Equipment (disposable aprons) to protect Health and Care workers for contracting the Covid-19 disease.
II.1.6) Information sur les lots Ce marchÈ est divisÈ en lots: non
II.1.7) Valeur totale du marchÈ (hors TVA) Valeur hors TVA: 14 400 000.00 GBP
II.2) Description
II.2.3) Lieu d'exÈcution Code NUTS: UK UNITED KINGDOM
II.2.4) Description des prestations:
The Department of Health and Social Care (the ëAuthorityí) has awarded a contract to Uniserve Group for the supply of Personal Protective Equipment (disposable aprons) to protect Health and Care workers for contracting the Covid-19 disease.
II.2.5) CritËres díattribution Prix
II.2.11) Information sur les options Options: non
II.2.13) Information sur les fonds de l'Union europÈenne
Le contrat s'inscrit dans un projet/programme financÈ par des fonds de l'Union europÈenne: non
II.2.14) Informations complÈmentaires
Section IV: ProcÈdure
IV.1) Description
IV.1.1) Type de procÈdure Attribution d'un marchÈ sans publication prÈalable d'un avis d'appel la concurrence au Journal officiel de líUnion europÈenne (dans les cas ÈnumÈrÈs ci-dessous) Explication:
 1)The Coronavirus disease (Covid-19) is a serious infectious respiratory disease and its consequences pose a risk to life. The Covid-19 outbreak is a public health emergency of international concerns as declared by the World Health Organisation on 30 January 2020. The WHO Director General characterised Covid-19 as a pandemic on 11 March 2020, by this stage Europe was the centre of the pandemic. 2) The use of Personal Protective Equipment (PPE) is critical in safeguarding the health and lives of the care professionals treating patients with Covid-19. Delays in procuring the PPE poses a risk to life of those on the front line and the likelihood of significantly increased death toll. 3) In March the NHS experienced severe shortages of PPE, modelling based the trajectory of other European countries forecast the need for significant and extremely rapid increase in the UK PPE capacity. Similar shortfalls in PPE stocks were identified globally. There was immense demand for PPE, requiring the UK government to actively seek and create new supply chains rapidly to meet that demand. In these circumstances, a procurement following the usual timescales under the PCR 2015, including accelerated options, was impossible. PPE manufacturers and supply chains were under immediate and unprecedented global pressure to provide products. A delay in engaging with the market by running a usual procurement process ran the risk of failing to acquire the necessary stock of PPE equipment and presenting a significant risk to life. 4) The Department for Health and Social Care (ëDHSCí) is satisfied the tests permitting use of the negotiated procedure without prior publication (Regulation 32(2)(c)) were met: A. As far as is strictly necessary: PPE was identified as strictly necessary to meet anticipated demand on the NHS during the first wave of cases in the UK. B. There are genuine reasons for extreme urgency: DHSC are responding to Covid-19 immediately because of public health risks presenting a genuine emergency. C. The events that have led to the need for extreme urgency were unforeseeable: as the Commission itself confirmed: ëThe current Coronavirus crisis presents an extreme and unforeseeable urgency ñ precisely for such a situation our European rules enable public buyers to buy within a matter of days, even hours, if necessary.í (Commissioner Breton, Internal Market, 1 April 2020). D. It was impossible to comply with the usual timescales in the PCR: due to the urgency of the situation there was no time to run an accelerated procurement under the open, restricted or competitive procedures with negotiation that would allow DHSC to secure delivery of products, particularly in light of the corresponding delays to timelines associated with securing supply of the PPE equipment. E. The situation is not attributable to the contracting authority: DHSC has not caused or contributed to the Coronavirus crisis, which justifies the need for extreme urgency.
IV.1.3) Information sur l'accord-cadre ou le systËme d'acquisition dynamique
IV.1.8) Information concernant líaccord sur les marchÈs publics (AMP)
Le marchÈ est couvert par l'accord sur les marchÈs publics: oui
IV.2) Renseignements d'ordre administratif
IV.2.8) Informations sur l'abandon du systËme d'acquisition dynamique
IV.2.9) Informations sur l'abandon de la procÈdure d'appel la concurrence sous la forme d'un avis de prÈinformation
Section V: Attribution du marchÈ

Un marchÈ/lot est attribuÈ: oui
V.2) Attribution du marchÈ
V.2.1) Date de conclusion du marchÈ:
V.2.2) Informations sur les offres Nombre d'offres reÁues: 1
Le marchÈ a ÈtÈ attribuÈ un groupement d'opÈrateurs Èconomiques: non
V.2.3) Nom et adresse du titulaire Nom officiel: Uniserve NumÈro national d'identification: 1826635 Adresse postale: Upminster Court 133 Hall Lane Ville: Upminster Code NUTS: UK UNITED KINGDOM Code postal: RM14 1AL Pays: Royaume-Uni
Le titulaire est une PME: non
V.2.4) Informations sur le montant du marchÈ/du lot (hors TVA) Estimation initiale du montant total du marchÈ/du lot: 14 400 000.00 GBP Valeur totale du marchÈ/du lot: 14 400 000.00 GBP
V.2.5) Information sur la sous-traitance
Section VI: Renseignements complÈmentaires
VI.3) Informations complÈmentaires:
VI.4) ProcÈdures de recours
VI.4.1) Instance chargÈe des procÈdures de recours Nom officiel: The High Court Adresse postale: Strand Ville: London Code postal: WC2A 2LL Pays: Royaume-Uni Adresse internet:
VI.5) Date díenvoi du prÈsent avis:
C L A S S E    C P V
35113410 - Vêtements de protection biologique et chimique